Affiliations
AffiliationsItem in Clipboard
Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at DiagnosisBrandon J Diessner et al. JAMA Netw Open. 2020.
. 2020 Aug 3;3(8):e2011087. doi: 10.1001/jamanetworkopen.2020.11087. AffiliationsItem in Clipboard
AbstractImportance: Approximately 10% to 30% of patients with sarcoma present with detectable metastases at diagnosis. However, the extent to which presentation with metastases is due to delayed diagnosis vs other factors remains unclear.
Objective: To evaluate whether socioeconomic status, insurance status, or race/ethnicity were associated with the presence of metastases at diagnosis of sarcoma.
Design, setting, and participants: This cross-sectional study used data from the population-based Surveillance, Epidemiology, and End Results program. Adult and pediatric patients with an initial diagnosis of soft-tissue and bone sarcoma between 2001 and 2015 were stratified by age group (pediatric, <20 years; adult, 20-65 years; older adult, >65 years) and sarcoma subtype. Statistical analyses were performed between August 2019 and January 2020.
Exposures: Surveillance, Epidemiology, and End Results Census tract-level socioeconomic status index, insurance status, and race/ethnicity.
Main outcomes and measures: The odds of presenting with metastases at diagnosis were calculated.
Results: A total of 47 337 patients with first primary malignant sarcoma were included (24 343 male patients [51.4%]), with 29 975 non-Hispanic White patients (63.3%), 5673 non-Hispanic Black patients (12.0%), 7504 Hispanic patients (15.8%), and 4185 American Indian-Alaskan Native and Asian Pacific Islander patients (8.8%). Liposarcoma in adults was the only subtype and age group combination that demonstrated a significant trend in incidence across socioeconomic status levels (odds ratio, 0.85; 99% CI, 0.76-0.96; P = .001). However, compared with having non-Medicaid insurance, having Medicaid or no insurance in adults was associated with an increased odds of metastases at diagnosis for 6 of the 8 sarcoma subtypes evaluated; osteosarcoma and Ewing sarcoma were the only 2 subtypes in adults for which metastases were not associated with insurance status. In addition, there was an increased risk of presenting with metastases among non-Hispanic Black adults diagnosed with leiomyosarcoma (odds ratio, 1.87; 99% CI, 1.41-2.48) and unclassified sarcomas (odds ratio, 1.65; 99% CI, 1.01-2.67) compared with non-Hispanic White adults that was independent of socioeconomic and insurance status.
Conclusions and relevance: These findings suggest that delayed access to care is associated with advanced stage at diagnosis for several soft-tissue sarcoma subtypes in adults, whereas other factors may be associated with the metastatic progression of osteosarcoma and Ewing sarcoma, as well as the racial disparities observed with metastatic leiomyosarcoma and unclassified sarcomas.
Conflict of interest statementConflict of Interest Disclosures: None reported.
FiguresFigure 1.. Multivariable Adjusted Odds Ratios (ORs)…
Figure 1.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma by Socioeconomic…
Figure 1.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma by Socioeconomic Status, Stratified by Age Group and Sarcoma Subtype: Surveillance, Epidemiology, and End Results 16 Registries, 2001-2015All data are adjusted for race, sex, age at diagnosis, and year of diagnosis. ARMS indicates alveolar rhabdomyosarcoma; DSRCT, desmoplastic small round cell tumor; ES, Ewing sarcoma; F/MF, fibroblastic or myofibroblastic; GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; RMS, rhabdomyosarcoma; and UPS, undifferentiated pleomorphic sarcoma.
Figure 2.. Multivariable Adjusted Odds Ratios (ORs)…
Figure 2.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma in non-Hispanic…
Figure 2.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma in non-Hispanic Black vs non-Hispanic White Patients, Stratified by Age Group and Sarcoma Subtype: Surveillance, Epidemiology, and End Results 16 Registries, 2001-2015All data are adjusted for small-area socioeconomic status (ordinal variable), sex, age at diagnosis, and year of diagnosis. ARMS indicates alveolar rhabdomyosarcoma; DSRCT, desmoplastic small round cell tumor; ES, Ewing sarcoma; F/MF, fibroblastic or myofibroblastic; GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; RMS, rhabdomyosarcoma; and UPS, undifferentiated pleomorphic sarcoma.
Figure 3.. Multivariable Adjusted Odds Ratios (ORs)…
Figure 3.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma in Hispanic…
Figure 3.. Multivariable Adjusted Odds Ratios (ORs) and 99% CIs for Metastatic Sarcoma in Hispanic vs non-Hispanic White Patients, Stratified by Age Group and Sarcoma Subtype: Surveillance, Epidemiology, and End Results 16 Registries, 2001-2015ARMS indicates alveolar rhabdomyosarcoma; DSRCT, desmoplastic small round cell tumor; ES, Ewing sarcoma; F/MF, fibroblastic or myofibroblastic; GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; RMS, rhabdomyosarcoma; and UPS, undifferentiated pleomorphic sarcoma.
Figure 4.. Multivariable Adjusted Odds Ratios (ORs)…
Figure 4.. Multivariable Adjusted Odds Ratios (ORs) for Metastatic Sarcoma in American Indian and Alaska…
Figure 4.. Multivariable Adjusted Odds Ratios (ORs) for Metastatic Sarcoma in American Indian and Alaska Native (AIAN) or Asian Pacific Islander (API) Patients vs non-Hispanic White Patients, Stratified by Age Group and Sarcoma Subtype: Surveillance, Epidemiology, and End Results 16 Registries, 2001-2015ARMS indicates alveolar rhabdomyosarcoma; DSRCT, desmoplastic small round cell tumor; ES, Ewing sarcoma; F/MF, fibroblastic or myofibroblastic; GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; RMS, rhabdomyosarcoma; and UPS, undifferentiated pleomorphic sarcoma.
Similar articlesKo NY, Hong S, Winn RA, Calip GS. Ko NY, et al. JAMA Oncol. 2020 Mar 1;6(3):385-392. doi: 10.1001/jamaoncol.2019.5672. JAMA Oncol. 2020. PMID: 31917398 Free PMC article.
Smartt AA, Jang ES, Tyler WK. Smartt AA, et al. Clin Orthop Relat Res. 2020 Mar;478(3):527-536. doi: 10.1097/CORR.0000000000000889. Clin Orthop Relat Res. 2020. PMID: 31390340 Free PMC article.
Holt HK, Peterson CE, MacLaughlan David S, Abdelaziz A, Sawaya GF, Guadamuz JS, Calip GS. Holt HK, et al. JAMA Netw Open. 2023 Mar 1;6(3):e232985. doi: 10.1001/jamanetworkopen.2023.2985. JAMA Netw Open. 2023. PMID: 36897588 Free PMC article.
Lechtholz-Zey E, Bonney PA, Cardinal T, Mendoza J, Strickland BA, Pangal DJ, Giannotta S, Durham S, Zada G. Lechtholz-Zey E, et al. World Neurosurg. 2022 Feb;158:65-83. doi: 10.1016/j.wneu.2021.10.150. Epub 2021 Oct 27. World Neurosurg. 2022. PMID: 34718199 Review.
Roberts B, Cooke-Barber J, Ingram MC, Danko M, Trudeau M, Glick RD, Short SS, Robertson DJ, Raval MV, Dasgupta R, Rich BS; American Academy of Pediatrics Section on Surgery Delivery of Surgical Care Committee. Roberts B, et al. Pediatr Blood Cancer. 2023 Jul;70(7):e30355. doi: 10.1002/pbc.30355. Epub 2023 Apr 17. Pediatr Blood Cancer. 2023. PMID: 37066595 Review.
Mani K, Kleinbart E, Schlumprecht A, Golding R, Akioyamen N, Song H, De La Garza Ramos R, Eleswarapu A, Yang R, Geller D, Hoang B, Yassari R, Fourman MS. Mani K, et al. Ann Surg Oncol. 2024 Aug;31(8):4882-4893. doi: 10.1245/s10434-024-15299-5. Epub 2024 Jun 11. Ann Surg Oncol. 2024. PMID: 38861205 Free PMC article.
Dahl M, Aurit SJ, Silberstein PT, Gootee J. Dahl M, et al. Cureus. 2021 Oct 31;13(10):e19163. doi: 10.7759/cureus.19163. eCollection 2021 Oct. Cureus. 2021. PMID: 34873506 Free PMC article.
Koons A, Smith E, Stephens JC, McKnight NH, Barr J, Ibe IK. Koons A, et al. Curr Rev Musculoskelet Med. 2024 Dec;17(12):527-537. doi: 10.1007/s12178-024-09925-8. Epub 2024 Sep 24. Curr Rev Musculoskelet Med. 2024. PMID: 39316352 Free PMC article. Review.
Zhuang A, Fang Y, Heger M, Ma L, Xu J, Wang J, Lu W, Tong H, Zhou Y, Zhang Y. Zhuang A, et al. J Clin Transl Res. 2022 Nov 24;8(6):584-593. eCollection 2022 Dec 29. J Clin Transl Res. 2022. PMID: 36683651 Free PMC article.
Watson RR, Niedziela CJ, Nuzzi LC, Netson RA, McNamara CT, Ayannusi AE, Flanagan S, Massey GG, Labow BI. Watson RR, et al. Plast Reconstr Surg Glob Open. 2024 May 17;12(5):e5831. doi: 10.1097/GOX.0000000000005831. eCollection 2024 May. Plast Reconstr Surg Glob Open. 2024. PMID: 38798939 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3